[Federal Register: October 14, 2010 (Volume 75, Number 198)]
[Notices]
[Page 63215-63216]
[DOCID:fr14oc10-120]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Proposed Collection; Comment Request

Upon Written Request, Copies Available From: Securities and Exchange
Commission, Office of Investor Education and Advocacy, Washington, DC
20549-0213.

Extension:
    Form 6-K; OMB Control No. 3235-0116; SEC File No. 270-107.

    Notice is hereby given that, pursuant to the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange
Commission (``Commission'') is soliciting comments on the collection of
information summarized below. The Commission plans to submit this
existing collection of information to the Office of Management and
Budget for extension and approval.
    Form 6-K (17 CFR 249.306) is a disclosure document under the
Securities Exchange Act of 1934 (15 U.S.C. 78a et seq.) that must be
filed by a foreign private issuer to report material information
promptly after the occurrence of specified or other

important corporate events that are disclosed in the foreign private
issuer's home country. The purpose of Form 6-K is to ensure that U.S.
investors have access to the same information that foreign investors do
when making investment decisions. Form 6-K takes approximately 8.7
hours per response and is filed by approximately 12,022 issuers
annually. We estimate that 75% of the 8.7 hours per response (6.525
hours) is prepared by the issuer for a total annual reporting burden of
78,444 hours (6.525 hours per response x 12,022 responses).
    Written comments are invited on: (a) Whether this collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information will have practical
utility; (b) the accuracy of the agency's estimate of the burden
imposed by the collection of information; (c) ways to enhance the
quality, utility, and clarity of the information collected; and (d)
ways to minimize the burden of the collection of information on
respondents, including through the use of automated collection
techniques or other forms of information technology. Consideration will
be given to comments and suggestions submitted in writing within 60
days of this publication.
    Please direct your written comments to Jeffrey Heslop, Acting
Director/CIO, Securities and Exchange Commission, C/O Remi Pavlik-
Simon, 6432 General Green Way, Alexandria, Virginia 22312; or send an
e-mail to<EMAIL_ADDRESS>
    Dated: October 6, 2010.
Florence E. Harmon,
Deputy Secretary.
[FR Doc. 2010-25865 Filed 10-13-10; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 79, Number 83 (Wednesday, April 30, 2014)]
[Notices]
[Pages 24419-24425]
[FR Doc No: 2014-09888]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OW-2014-0138; FRL-9910-21-OW]

Peer Review of the Draft Health Effects Documents for
Perfluorooctanoic Acid and Perfluorooctane Sulfonate--Interim List of
Potential Peer Reviewers

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice; request for public comments.

-----------------------------------------------------------------------

SUMMARY: Environmental Protection Agency (EPA) requests public comments
on the interim list of candidates being

considered as peer reviewers for the contractor-managed external peer
review of the draft documents entitled, ``Health Effects Document for
Perfluorooctanoic Acid'' and ``Health Effects Document for
Perfluorooctane Sulfonate.'' This notice provides the names,
professional affiliations, expertise, education, and professional
experience of the candidate reviewers. The public is requested to
provide relevant information or documentation on the candidates who are
being evaluated by the contractor (Versar, Inc.). Once the public
comments on the interim list of candidates have been reviewed and
considered, Versar will select the final six to seven peer reviewers
who, collectively, best provide expertise spanning the multiple subject
matter areas covered by the draft documents and, to the extent
feasible, best provide a balance of perspectives.

DATES: The public comment period on the interim list of peer reviewers
begins on April 30, 2014 and ends on May 21, 2014.

ADDRESSES: Any interested person or organization may submit comments on
the interim list of peer reviewers. Public comments should be submitted
to the EPA contractor, Versar, Inc., no later than May 21, 2014, by one
of the following methods:
     Online: http://peerreview.versar.com/epa/pfoa/interim-list.html.
     Email<EMAIL_ADDRESS>(subject line: PFOA/PFOS Peer
Review).
     Mail: Versar, Inc., 6850 Versar Center, Springfield, VA
22151 (ATTN: Betzy Colon).
    Please be advised that public comments are subject to release under
the Freedom of Information Act.

FOR FURTHER INFORMATION CONTACT: Questions concerning the comment
process or Web site should be directed to the EPA contractor, Versar,
Inc., at 6850 Versar Center, Springfield, VA 22151; by email
<EMAIL_ADDRESS>(subject line: PFOA/PFOS Peer Review); or by
phone:<PHONE_NUMBER> (ask for Betzy Colon). For additional information
concerning the health effects documents, please contact Joyce Donohue
at U.S. EPA, Office of Water, Health and Ecological Criteria Division
(Mail Code 4304T), 1200 Pennsylvania Avenue NW., Washington, DC 20460;
telephone:<PHONE_NUMBER>; or email<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background Information on the Draft Health Effects Documents

    EPA has prepared draft health effects documents for
Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) for
purposes of public comment (scientific views) and peer review. EPA will
consider any public comments and peer reviewer comments submitted in
accordance with the Federal Register notice dated February 24, 2014
(http://www.gpo.gov/fdsys/pkg/FR-2014-02-28/pdf/2014-04455.pdf) when
finalizing the documents. Once the health effects documents are
finalized, they will be utilized to develop lifetime health advisory
values for each chemical. PFOA and PFOS are listed on the third
contaminant Candidate List (CCL3) \1\ and both chemicals are currently
being monitored under the third Unregulated Contaminant Monitoring Rule
(UCMR3) \2\. The draft documents are available through
www.regulations.gov (docket ID number EPA-HQ-OW-2014-0138) and at
http://peerreview.versar.com/epa/pfoa.
---------------------------------------------------------------------------

    \1\ CCL3 is a list of contaminants that are currently not
subject to any proposed or promulgated national primary drinking
water regulations, that are known or anticipated to occur in public
water systems, and which may require regulation under the Safe
Drinking Water Act (SDWA). Additional information about the CCL3 can
be found at the following Web site: http://water.epa.gov/scitech/drinkingwater/dws/ccl/ccl3.cfm.
    \2\ EPA uses the Unregulated Contaminant Monitoring (UCM)
program to collect data for unregulated contaminants suspected to be
present in drinking water. Results from UCMR3 can be examined as
they become available at the following Web site: http://water.epa.gov/lawsregs/rulesregs/sdwa/ucmr/ucmr3/.
---------------------------------------------------------------------------

II. Process of Obtaining Candidate Reviewers

    On February 24, 2014, EPA released the draft health effects
documents on PFOA and PFOS for the purposes of public comment and peer
review. Consistent with guidelines for the peer review of highly
influential scientific assessments, EPA tasked a contractor (Versar,
Inc.) to assemble six to seven scientific experts to evaluate the draft
documents. As part of the peer review process, a public nomination
period was held from February 24, 2014 to March 21, 2014, during which
members of the public were able to nominate scientific experts with
knowledge and experience in one or more of the following areas: (1)
Epidemiology, (2) toxicology (liver effects, immunotoxicity,
neurotoxicity, developmental and reproductive toxicology, etc.), (3)
membrane transport, (4) human health risk assessment, (5)
pharmacokinetic models, and (6) mode-of-action for cancer and noncancer
effects. Versar also conducted an independent search for scientific
experts to augment the list of publically-nominated candidates. In
total, Versar evaluated the 29 candidates nominated during the public
nomination period and identified by Versar.
    Selection Process: Versar considered and screened all candidates
against the selection criteria described in the Federal Register dated
February 24, 2014 (http://www.gpo.gov/fdsys/pkg/FR-2014-02-28/pdf/2014-04455.pdf), which included having demonstrated expertise in the areas
described above, being free of any conflict of interest, and being
available to participate in-person in a two-day peer review meeting in
the Washington, DC area (exact date to be determined). Following the
screening process, Versar narrowed the list of potential reviewers to
15 candidates. This Federal Register notice is to solicit comments on
the interim list of 15 candidates. The public is requested to provide
relevant information or documentation on the candidates who are being
evaluated by Versar. Once the public comments on the interim list of
candidates have been reviewed and considered, Versar will select the
final six to seven peer reviewers. Additional information on the
scientific peer review process can be found at: http://peerreview.versar.com/epa/pfoa.
    Responsibilities of Peer Reviewers: Peer reviewers will be charged
with evaluating and preparing written comments on the draft PFOA and
PFOS health effects documents. Specifically, reviewers will provide
general comments, their overall impressions of the documents, and
respond to 12 charge questions. This includes determining the
appropriateness of the quality, accuracy, and relevance of the data in
the documents. Any public comments submitted to EPA's public docket
(docket ID number EPA-HQ-OW-2014-0138) during each document's 60-day
public comment period will also be provided to the peer reviewers for
their consideration. In addition, peer reviewers will participate in a
two-day peer review meeting to discuss the scientific basis supporting
EPA's draft health effects documents. The meeting will be held in the
Washington, DC metro area and is anticipated to take place in the late
July or August timeframe. Following the peer review meeting, Versar
will provide a peer review summary report to EPA containing the
comments and recommendations from the peer reviewers. The final peer
review report will also be made available to the public. In preparing
the final health effects documents, EPA will consider Versar, Inc.'s
report of the comments and recommendations from the external peer
review meeting, as well as written public comments received through the
official public docket.

III. Interim List of Peer Reviewers

    Following are the names, professional affiliations, expertise,
education, and professional experience of the current candidates being
considered for the external peer review of the draft PFOA and PFOS
Health Effects documents. After review and consideration of any public
comments received, Versar will select from this list the final six to
seven peer reviewers who, collectively, best provide expertise spanning
the multiple areas listed above and, to the extent feasible, best
provide a balance of perspectives. Once the final six to seven peer
reviewers are selected by Versar, a third Federal Register notice will
be published at least 30 days prior to the external peer review meeting
with the names of the final peer reviewers, along with information on
the meeting date, location, and registration details.
    1. John C. Bailar III, M.D., Ph.D., University of Chicago
(Emeritus).
    i. Expertise: Epidemiology and Human Health Risk Assessment.
    ii. Education: Yale University, M.D. (1955) and American
University, Ph.D. in Statistics (1973).
    iii. Professional Experience: Dr. Bailar is Professor Emeritus at
the University of Chicago, where he was founding Chair of the
Department of Health Studies. Prior to joining the University of
Chicago, Dr. Bailar was at the U.S. National Cancer Institute from
1956-1980, Harvard University 1980-1988, and McGill University (where
he was Chair of Epidemiology and Biostatistics) 1988-1995. Since he
retired in 2001, Dr. Bailar has been Scholar in Residence at the
National Academies. Dr. Bailar received his M.D. from Yale University
in 1955 and his Ph.D. in Statistics from American University in 1973.
His areas of expertise include statistics, biostatistics, epidemiology,
and environmental and occupational hazards. For many years his
professional interests centered on the causes and prevention of
disease. More recently he has focused on improving quality and
performance in science generally, with a special focus on
communication. Dr. Bailar has served on more than 40 committees at the
National Academies, and served as chair or co-chair of 13 of these
committees. Dr. Bailar has received numerous special/prestigious
honors, awards and recognitions, including MacArthur Fellow 1990-1995,
elected member to both the Institute of Medicine and the International
Statistical Institute, honorary Fellow, American Medical Writers
Association, and most recently an Honored Member of the Board of
Editors in the Life Sciences. In addition, for 11 years, he was the
statistical consultant and a member of the editorial board for The New
England Journal of Medicine. Association memberships of Dr. Bailar
include the American Statistical Association (life member) and Council
of Science Editors (Past President). Dr. Bailar has more than 250
scientific publications including articles in peer reviewed journals,
books, book chapters, and proceedings, and has published widely in the
statistics and epidemiology literature.
    2. James V. Bruckner, Ph.D., University of Georgia.
    i. Expertise: Toxicology (liver effects, neurotoxicology, and
developmental/reproductive) and Human Health Risk Assessment.
    ii. Education: University of Michigan, Ph.D. in Toxicology (1974).
    iii. Professional Experience: Dr. Bruckner is currently Professor
of Pharmacology and Toxicology at the University of Georgia College of
Pharmacy. He is also Professor in the Department of Physiology and
Pharmacology at the University of Georgia College of Veterinary
Medicine. He received his Ph.D. in Toxicology from the University of
Michigan in 1974. He has previously held faculty positions at the
University of Kansas and the University of Texas Medical School at
Houston. He is actively engaged in graduate education and in federally-
funded research projects. Dr. Bruckner's research focus is on the
toxicology and toxicokinetics of solvents, drug-solvent interactions at
occupational exposure levels, and toxicokinetic bases for
susceptibility of children to insecticides and other chemicals. Dr.
Bruckner has published more than 200 journal articles, book chapters,
and abstracts. He has also served on a variety of expert panels and
committees for the EPA, National Institutes of Health, National
Aeronautics and Space Administration, Agency for Toxic Substances and
Disease Registry, Food and Drug Administration, and National Academy of
Sciences.
    3. Deborah A. Cory-Slechta, Ph.D., University of Rochester School
of Medicine and Dentistry.
    i. Expertise: Toxicology (neurotoxicology and developmental/
reproductive) and Human Health Risk Assessment.
    ii. Education: University of Minnesota, Ph.D. in Experimental
Psychology (1977).
    iii. Professional Experience: Dr. Cory-Slechta is currently a
Professor in the Department of Environmental Medicine and the
Department of Pediatrics at the University of Rochester School of
Medicine and Dentistry, where she also serves as co-director of the
Behavioral Sciences Facility Core and director of the Animal Behavior
Core. Dr. Cory-Slechta received her Ph.D. from the University of
Minnesota in 1977 and worked as a junior staff fellow of the Food and
Drug Administration (FDA) National Center for Toxicological Research
(NCTR) beginning in 1979. She was appointed to the faculty of the
University of Rochester Medical School in 1982 and was appointed Chair
of the Department of Environmental Medicine and Director of the
National Institute of Environmental Health Sciences (NIEHS)
Environmental Health Sciences Center at the University of Rochester in
1998. From 2000 to 2002, she was the Dean for Research and Director of
the AAB Institute for Biomedical Sciences. Following her appointment as
Dean, she served from 2003 to 2007 as the Chair of the Department of
Environmental and Occupational Medicine at Robert Wood Johnson Medical
School and as Director of the Environmental and Occupational Health
Sciences Institute, a joint Institute of the Robert Wood Johnson
Medical School and Rutgers. Dr. Cory-Slechta's research has focused
largely on environmental neurotoxicants as risk factors for behavioral
disorders and neurodegenerative disease. These research efforts have
resulted in over 170 papers and book chapters to date. Dr. Cory-Slechta
has served on numerous national research review and advisory panels,
including committees of the National Institutes of Health, NIEHS, NCTR,
EPA, National Academy of Sciences, Institute of Medicine, and the
Agency for Toxic Substances and Disease Registry, Centers for Disease
Control. In addition, Dr. Cory-Slechta has served on the editorial
boards of several journals including Environmental Health Perspectives,
Neurotoxicology, Toxicology, Toxicological Sciences, Fundamental and
Applied Toxicology, Neurotoxicology and Teratology, and American
Journal of Mental Retardation. She has held the elected positions of
President of the Neurotoxicology Specialty Section of the Society of
Toxicology, President of the Behavioral Toxicology Society, and been
named a Fellow of the American Psychological Association.
    4. Jamie C. DeWitt, Ph.D., East Carolina University.
    i. Expertise: Toxicology (immunotoxicology, neurotoxicology, and
developmental).
    ii. Education: Indiana University, Ph.D. in Environmental Science
and Neural Science (2004).

    iii. Professional Experience: Dr. DeWitt is an Assistant Professor
in the Department of Pharmacology and Toxicology at the Brody School of
Medicine at East Carolina University (ECU). She is affiliated with The
Harriet and John Wooten Laboratory for Alzheimer's and
Neurodegenerative Diseases Research and holds an adjunct appointment in
the ECU Department of Public Health. Dr. DeWitt received her Ph.D. in
Environmental Science and Neural Science from the School of Public and
Environmental Affairs and Program in Neural Science at Indiana
University in 2004. She also completed postdoctoral training in
Developmental Cardiotoxicity at Indiana University-Bloomington and in
Immunotoxicology at EPA through a cooperative training agreement with
the University of North Carolina at Chapel Hill. Dr. DeWitt's main
research focus is on how toxicants found in the environment can lead to
neurodevelopmental and neurodegenerative disorders via disruption of
the developing immune system. Much of her past research has involved
the immunotoxicity of PFOA and related polyfluoroalkyl substances
(PFASs). Dr. DeWitt has published seven peer reviewed research
articles, three review papers and two book chapters that address the
biological effects of PFOA, as well as one paper on the effects of PFOS
on immune function. Her publications describe effects as well as
underlying mechanisms following adult and developmental exposure. Her
research experience and publication record (more than 25 peer reviewed
manuscripts, 6 review articles, 9 book chapters) extend beyond the
effects of perfluoroalkyl acids and working with rodent models. She is
currently editing a book on the general toxicity of PFASs and is a
current member of the mechanistic working group for Monograph 110 of
the International Agency for Research on Cancer, which will include an
assessment of PFOA. She is on the editorial boards of the Journal of
Immunotoxicology and the Journal of Environmental Toxicology and Health
and has reviewed grants for the U.S. Department of Defense and the
National Institute of Occupational Safety and Health (NIOSH). She has
also been a manuscript reviewer for more than 20 journals. Dr. DeWitt
is the current president of the North Carolina chapter of the Society
of Toxicology (SOT) and the Junior Councilor for the Immunotoxicology
Specialty Section of the SOT. She also was awarded the Outstanding
Young Investigator Award from the Immunotoxicology Specialty Section in
2013.
    5. Neeraja K. Erraguntla, Ph.D., DABT, Texas Commission on
Environmental Quality.
    i. Expertise: Toxicology (liver effects, neurotoxicology,
immunotoxicology, and developmental/reproductive) and Human Health Risk
Assessment.
    ii. Education: Louisiana State University, Ph.D. in Physiology,
Pharmacology, & Toxicology (1998).
    iii. Professional Experience: Dr. Erraguntla is currently a Senior
Toxicologist/Project Manager at the Texas Commission on Environmental
Quality (TCEQ). She is also an Adjunct Assistant Professor at Texas A&M
School of Public Health. Dr. Erraguntla received her Ph.D. in
Physiology, Pharmacology, and Toxicology from Louisiana State
University in 1998. Prior to joining TCEQ, Dr. Erraguntla served as a
Scientific Advisor at Life Technologies (2001-2004) and as a Research
Fellow/Research Associate at the University of Texas Southwestern
Medical Center (1998-2001). Dr. Erraguntla was board-certified as a
Diplomate of the American Board of Toxicology in 2012. Her work focuses
on air toxics, multimedia risk assessment, and development of toxicity
factors for various industrial chemicals. This involves general review
of toxicological studies, weight-of-evidence (WOE) analysis by the
integration of science along multiple lines of evidence (epidemiology,
in vivo & in vitro experimental toxicology, and human clinical studies)
and advising staff on hazard classification. Dr. Erraguntla is also a
team leader working on developing a framework for conducting systematic
reviews and determining WOE for toxicity factors. Dr. Erraguntla has
been an invited speaker at over eight national and state/regional
meetings. She is currently a member of EPA's Science Advisory Board
Environmental Justice Technical Guidance Panel and has been a member of
EPA's Acute Exposure Guideline Levels Committee. Dr. Erraguntla has
also been a full member of the Society of Toxicology (SOT) since 2011
and has supported SOT's Specialty Sections and Special Interest Groups.
    6. Penelope A. Fenner-Crisp, Ph.D., DABT, Independent Consultant.
    i. Expertise: Human Health Risk Assessment and Mode-of-Action.
    ii. Education: University of Texas Medical Branch, Ph.D. in
Pharmacology (1968).
    iii. Professional Experience: Dr. Fenner-Crisp has over 35 years of
experience in human health and ecological risk assessments and is
currently an independent consultant after retiring from her position as
the Executive Director of the International Life Sciences Institute
(ILSI) Risk Science Institute (2000-2004). Prior to joining ILSI, Dr.
Fenner-Crisp was employed by EPA, where she served in a variety of
capacities for over 22 years (1978-2000) including Senior Science
Advisor to the Director and Deputy Director of the Office of Pesticide
Programs, Director of the Health Effects Division of the Office of
Pesticide Programs, Director of the Health and Environmental Review
Division of the Office of Pollution Prevention and Toxic Substances,
and Senior Toxicologist in the Health Effects Branch of the Office of
Drinking Water. She was a charter member of EPA's Risk Assessment Forum
(RAF), a group of EPA senior scientists who are experts in all areas of
human, ecological, and exposure assessment, and served as the RAF chair
from 1998 until her retirement from EPA in 2000. Dr. Fenner-Crisp
received her Ph.D. in Pharmacology from the University of Texas Medical
Branch in Galveston in 1968 and completed a Postdoctoral Fellowship in
Pharmacology at Georgetown University Schools of Medicine and Dentistry
(1971-1976), with an emphasis on reproductive endocrinology. Her 35
years of experience includes hands-on practice, and management
oversight, of all components of both human health and ecological risk
assessments related to drinking water contaminants, industrial
chemicals, pesticides and foodborne pathogens. Dr. Fenner-Crisp has
served on numerous committees and panels including expert panels
charged with the review of EPA Integrated Risk Information System
documents, EPA Advisory Committees, EPA Science Advisory Board Drinking
Water Committee, and several World Health Organization Panels, to name
a few. She has also played a key role in the development of many EPA
science policies, including the policy guidance for use of Monte Carlo
analyses in exposure assessment, the cumulative risk conceptual
framework, implementation of the cancer guidelines, and those relevant
to implementation of the 1996 Food Quality Protection Act. Dr. Fenner-
Crisp is a member of the Society of Toxicology since 1983, and the
Society for Risk Analysis (SRA) since 1981, where she was the recipient
of the SRA's first Risk Practitioner award. She has been a Diplomate of
the American Board of Toxicology since 1984 and served a four-year term
on its Board of Directors from 2001-2005. Dr. Fenner-Crisp has

been an invited speaker at over 100 national and international meetings
and workshops, and has authored or co-authored over 40 publications,
including peer-reviewed journal articles, reports, and book chapters.
    7. Jeffrey W. Fisher, Ph.D., U.S. Food and Drug Administration.
    i. Expertise: Toxicology (developmental/reproductive), Human Health
Risk Assessment, and Pharmacokinetic Models.
    ii. Education: Miami University of Ohio, Ph.D. in Zoology/
Toxicology (1987).
    iii. Professional Experience: Dr. Fisher is currently a Research
Toxicologist at the U.S. Food and Drug Administration (FDA), National
Center for Toxicological Research. He was formerly a Professor in the
Department of Environmental Health Science, College of Public Health at
the University of Georgia (UGA). He joined UGA in 2000 and served as
Department Head of the Department of Environmental Health Sciences from
2000 to 2006 and Director of the Interdisciplinary Toxicology Program
from 2006-2010. Prior to joining UGA, he spent most of his career at
Wright Patterson Air Force Base, where he was Principal Investigator
and Senior Scientist in the Toxics Hazards Division and Technical
Advisor for the Operational Toxicology Branch. Dr. Fisher's research
interests are in the development and application of biologically based
mathematical models to ascertain health risks from environmental, food-
borne and occupational chemical exposures. Dr. Fisher's modeling
experience includes working with chlorinated and non-chlorinated
solvents, fuels, pesticides, perchlorate and bisphenol A. He has
developed physiologically-based pharmacokinetic (PBPK) models for use
in cancer risk assessment, estimating lactational transfer of solvents,
understanding in utero and neonatal dosimetry, quantifying metabolism
of solvent mixtures and developing biologically motivated models for
the hypothalamic-pituitary-thyroid axis in rodents and humans. Dr.
Fisher has published over 140 papers on pharmacokinetics and PBPK
modeling in laboratory animals and humans. He has served on several
national panels and advisory boards for the U.S. Department of Defense,
Agency for Toxic Substances and Disease Registry, EPA and non-profit
organizations. He was a U.S. delegate for the North Atlantic Treaty
Organization. Dr. Fisher served on the International Life Sciences
Institute Steering Committee, which evaluated chloroform and
dichloroacetic acid using EPA-proposed Carcinogen Risk Guidelines. He
is Past President of the Biological Modeling Specialty Section of the
Society of Toxicology, reviewer for several toxicology journals, and
was Co-Principal Investigator on a National Institutes of Health-
supported workshop on Mathematical Modeling at the University of
Georgia in the fall of 2003. Dr. Fisher was also a member of the
National Academy of Sciences subcommittee on Acute Exposure Guideline
Levels from 2004-2010 and for the EPA Science Advisory Board (SAB)
(2007-2010). He is an ad hoc EPA SAB member for dioxin and perchlorate.
Dr. Fisher is a Fellow of the Academy of Toxicological Sciences, an
associate editor for Toxicological Sciences, and on the editorial board
of Journal of Environmental Science and Health Part C Environmental
Carcinogenesis & Ecotoxicology Reviews.
    8. William L. Hayton, Ph.D., The Ohio State University.
    i. Expertise: Membrane Transport, Pharmacokinetic Models, and Mode-
of-Action.
    ii. Education: State University of New York, Ph.D. in Pharmaceutics
(1971).
    iii. Professional Experience: Dr. Hayton is a Professor Emeritus in
the College of Pharmacy at The Ohio State University. Dr. Hayton
received a Ph.D. in Pharmaceutics from the State University of New York
at Buffalo in 1967. He was a member of the Washington State University
College of Pharmacy faculty for 19 years, rising to Chair of the
Pharmacology/Toxicology Graduate Program in 1982 and Acting Dean at the
College of Pharmacy in 1987. In 1990, he transferred to the Ohio State
University as Chair of the Division of Pharmaceutics, where he later
served as Associate Dean for the Graduate Programs and Research until
his retirement in 2010. Dr. Hayton's expertise is pharmacokinetics,
particularly construction and validation of mathematical models that
describe or explain the kinetics of complex biological systems. One
recent research interest is characterization of the Fc receptor-
mediated transport and catabolism of albumin and IgG in wild type and
FcR knockout mice. A second recent project is the quantitative modeling
of the female hypothalamus-pituitary-gonad (HPG) axis in the female
rainbow trout (Oncorhynchus mykiss). The model is based on and
integrates the biology of gonadotropin, estrogen, androgen and
maturational hormone signaling systems, and it includes key
intermediate steps in the signaling pathways; viz., gonadotropin and
sex steroid synthesis, hormone receptors and their corresponding mRNA
levels. Dr. Hayton's expertise extends to interspecies scaling of
pharmacokinetic model parameter values and xenobiotic metabolism. Dr.
Hayton is author or co-author of over 100 peer-reviewed scientific
publications and has held peer-reviewed grant support from the National
Institutes of Health, EPA, U.S. Air Force Office of Scientific
Research, U.S. Food and Drug Administration, and U.S. Fish and Wildlife
Service. He previously served on the EPA Science Advisory Board
Perfluorooctanoic Acid Risk Assessment Review Panel.
    9. Matthew P. Longnecker, Sc.D, M.D., National Institute of
Environmental Health Sciences.
    i. Expertise: Epidemiology and Pharmacokinetic Models.
    ii. Education: Harvard School of Public Health, Sc.D. in
Epidemiology (1989); Dartmouth Medical School, M.D. (1981).
    iii. Professional Experience: Dr. Longnecker, M.D., Sc.D., is the
head of the Biomarker-based Epidemiology Group at the National
Institute of Environmental Health Sciences (NIEHS). Dr. Longnecker
received an M.D. from Dartmouth Medical School and completed a
residency in internal medicine at Temple University Hospital in
Philadelphia. After receiving a Sc.D. in Epidemiology from Harvard
School of Public Health in 1989, he served as an Assistant Professor in
the Department of Epidemiology at the University of California, Los
Angeles, School Of Public Health. Since 1996, Dr. Longnecker has served
as Adjunct Professor/Associate Professor in the Department of
Epidemiology, School of Public Health, University of North Carolina at
Chapel Hill. He came to the NIEHS Epidemiology Branch in 1995, as a
tenure-track investigator. Dr. Longnecker's research program is focused
on the health effects of persistent organic pollutants (e.g., the DDT
metabolite p,p'-DDE, and polychlorinated biphenyls). He is particularly
interested in the effects of intrauterine exposure to persistent
organic pollutants in relation to intrauterine growth, preterm birth,
birth defects, neurologic findings at birth, growth, neurodevelopment,
intelligence, and hearing. Recently, Dr. Longnecker has completed and
has ongoing a series of studies on perfluorinated alkyl substances in
relation to reproductive and pediatric outcomes. In addition, he has
begun studying the effects of early, low-level exposure to the
nonpersistent pollutants, bisphenol A and organophosphate pesticides.
Dr. Longnecker's research efforts have resulted in over 180 papers and
book chapters to date. He has served as a

leader for numerous national and international committees, such as for
the Society for Epidemiologic Research and the International Society
for Environmental Epidemiology, and has been on numerous national and
international scientific advisory boards, including the EPA Science
Advisory Board for the Perfluorooctanoic Acid Risk Assessment Review.
    10. Julie Melia, Ph.D., DABT, SRC, Inc.
    i. Expertise: Toxicology (neurotoxicology, developmental/
reproductive, liver effects), Human Health Risk Assessment, and Mode-
of-Action.
    ii. Education: Northeastern University, Ph.D. in Biomedical
Sciences/Toxicology (1990).
    iii. Professional Experience: Dr. Melia is currently a Senior
Toxicologist at SRC, Inc. where she has served as Program Manager and
provided toxicological support for several EPA programs and offices.
She is also an Adjunct Scientist and member of the Maine Center for
Toxicology and Environmental Health at the University of Southern
Maine. She received her Ph.D. in Biomedical Sciences/Toxicology from
Northeastern University in 1990 and has 24 years of experience in the
design and management of chemical toxicity evaluations and human health
and ecological risk assessments. Prior to joining SRC in 2003, Dr.
Melia was employed in the private sector, where she managed
multidisciplinary project teams and contributed to more than 50
Comprehensive Environmental Response, Compensation and Liability Act
(CERCLA), Resource Conservation and Recovery Act (RCRA), and state-
directed risk assessments. Dr. Melia was board-certified as a Diplomate
of the American Board of Toxicology in 2004 and has expertise in the
critical review of mechanistic toxicology studies and the evaluation of
chemical-specific modes of action. Dr. Melia has addressed complex
toxicological issues related to human exposure to many chemicals
including, phthalates, PAHs, polychlorinated biphenyls (PCBs),
pesticides (DDT, kepone), chlorinated solvents, brominated
trihalomethanes, 1,4-dioxane, and ethanol. She has demonstrated
innovative approaches to addressing challenging technical issues
related to chemical toxicology and risk assessment and has significant
experience in the critical review of epidemiology, toxicology, and
mechanistic studies and the development of quantitative toxicity
values. Dr. Melia has presented information to the EPA Science Advisory
Board and has served as an external peer reviewer for Agency for Toxic
Substances and Disease Registry Toxicological Profiles. She is a member
of the Society of Toxicology, and the International Society of
Regulatory Toxicology and Pharmacology.
    11. Andy L. Nong, Ph.D., Health Canada.
    i. Expertise: Pharmacokinetic Models.
    ii. Education: Universit[eacute] de Montr[eacute]al, Ph.D. in
Public Health (Toxicology) (2007).
    iii. Professional Experience: Dr. Nong is currently a Research
Scientist at the Environmental Health Sciences and Research Bureau at
Health Canada. He is also an Affiliate at the R. Samuel McLaughlin
Centre for Population Health Risk Assessment within the University of
Ottawa. He received his Ph.D. in Public Health from the
Universit[eacute] de Montr[eacute]al in 2007 and holds a Master's
degree in Pharmaceutical Sciences (2001). Prior to joining Health
Canada, Dr. Nong served as Research Investigator (2008-2009) and
Postdoctoral Fellow (2005-2008) at The Hamner Institutes for Health
Sciences. His work has been recognized, in particular, for
pharmacokinetics and biological modeling approaches in risk assessment.
Specifically, his research program explores the use of biological
computer models to simulate and interpret the fate and effects of
chemical exposure. This work has led to deriving drinking water dose
estimates, evaluating chemical mixture exposure, interpreting
biomonitoring and exposure surveys, and investigating models for
toxicity screening approaches for human equivalent chemical exposures.
Dr. Nong is a member of the expert panel for Genome Canada's
Bioinformatics and Computational Biology roadmap. His international
involvement includes a partnership with the EPA National Center for
Computational Toxicology and Toxicity Forecaster (ToxCast\TM\) program,
providing technical support for documents on PBPK modeling in risk
assessment for EPA and the World Health Organization/International
Program on Chemical Safety. Dr. Nong has authored and co-authored
several publications, including peer-reviewed articles and book
chapters, and served on the Board of Editors of the Journal of Applied
Toxicology.
    12. Stephen M. Roberts, Ph.D., University of Florida.
    i. Expertise: Toxicology (liver effects and immunotoxicology) and
Human Health Risk Assessment.
    ii. Education: University of Utah, Ph.D., Department of
Pharmacology (1973).
    iii. Professional Experience: Dr. Roberts is a Professor at the
University of Florida with joint appointments in the College of
Veterinary Medicine, College of Medicine, and College of Public Health
and Health Professions. He also serves as Director of the Center for
Environmental & Human Toxicology at the University of Florida. Dr.
Roberts received a Ph.D. from the University of Utah College of
Medicine Department of Pharmacology in 1973. After a National
Institutes of Health postdoctoral fellowship in pharmacokinetics at
SUNY Buffalo (1977-1980), he served on the faculties of the University
of Cincinnati College of Pharmacy (1980-1986) and the College of
Medicine at the University of Arkansas for Medical Sciences (1986-
1989). Dr. Roberts has been a faculty member at the University of
Florida since 1989. His research addresses mechanisms of toxicity,
particularly involving the liver and immune system. Dr. Roberts also
has an active research program in toxicokinetics, especially involving
bioavailability of environmental toxicants, as well as approaches to
evaluation of potential toxicity of nanomaterials. His teaching
responsibilities at the University of Florida include graduate courses
in toxicology and risk assessment, as well as invited lectures in other
graduate and professional courses. Dr. Roberts' research efforts have
resulted in over 100 papers and book chapters to date, as well as over
100 published abstracts and letters. Dr. Roberts has served on numerous
national advisory panels, including for the EPA, Department of Health
and Human Services, and the Food and Drug Administration. He is
currently the Associate Editor for Nanotoxicology and is currently or
recently on the Editorial Boards of Toxicology and Applied Toxicology,
Human and Ecological Risk Assessment, and Dose-Response.
    13. Angela L. Slitt, Ph.D., University of Rhode Island.
    i. Expertise: Toxicology (liver effects) and Membrane Transport.
    ii. Education: University of Connecticut, Ph.D. in Pharmacology and
Toxicology (2000).
    iii. Professional Experience: Dr. Slitt is currently an Associate
Professor in the Department of Biomedical and Pharmaceutical Sciences
at the University of Rhode Island. Dr. Slitt received her Ph.D. in
Pharmacology and Toxicology from the University of Connecticut in 2000,
and then served until 2004 as a postdoctoral fellow at the University
of Kansas Medical Center. Dr. Slitt has been a faculty member at the
University of Rhode

Island since 2006. Dr. Slitt's graduate and postdoctoral training was
heavily focused on liver biology and health, with a focus in the area
of toxicology, and included research in nuclear receptors,
biotransformation, and transporter expression. Her current research
interests focus on how (1) expression of drug transporters affects
chemical disposition and toxicity, (2) nutrition and intake of dietary
antioxidants affects the expression of drug transporters, (3) liver
disease (i.e., diabetes, cholestasis, and ethanol cirrhosis) affects
transporter expression and chemical disposition, and (4) transporter
expression affects cholesterol transport and susceptibility to
gallstone formation. She has also recently investigated the effect of
PFOS on caloric restriction in mice. Dr. Slitt is presently on the
Editorial Board of BMC Pharmacology and Toxicology, Journal of
Biochemical and Molecular Toxicology, and Toxicology Methods and
Mechanism, and is an ad-hoc reviewer for numerous other journals. She
is author or co-author of over 50 peer-reviewed scientific
publications, and was recently awarded the University of Rhode Island
Early Career Faculty Research Excellence Award.
    14. Calvin C. Willhite, Ph.D., Risk Sciences International and
McLaughlin Centre for Population Health Risk Assessment.
    i. Expertise: Toxicology (developmental/reproductive) and Human
Health Risk Assessment.
    ii. Education: Dartmouth Medical School, Ph.D. in Pharmacology
(1980).
    iii. Professional Experience: Dr. Willhite has more than 30 years
of experience in the fields of toxicology and human health risk
assessment. He is currently employed as a Contract Toxicologist for
Risk Sciences International and McLaughlin Centre for Population Health
Risk Assessment at the University of Ottawa, where he performs
chemical-specific human health risk assessments for Health Canada and
European Union REACH. Prior to his present employment, Dr. Willhite
also conducted chemical specific risk assessment as a Toxicologist for
the National Sanitation Foundation (2005-2012) and for the State of
California (1985-2011). He received his Ph.D. in Pharmacology from the
Dartmouth Medical School in 1980. Dr. Willhite has more than 100
publications in basic and applied toxicology and human health risk
assessment. He has experience with many types of compounds including
chemicals in occupational, submarine and ambient air; drugs in
dermatology; endocrine-active drugs and environmental chemicals;
inorganic elements; and dietary supplements. His editorial
responsibilities include serving on the Editorial Board and/or as
Reviewer of many peer reviewed toxicology journals. He is currently
serving on the Editorial Board of Toxicology and Applied Toxicology,
Journal of Toxicology, Journal of Toxicology and Environmental Health
Part A, and the International Journal of Toxicology. He has been a
member of the National Academy of Sciences Committee on Toxicology, EPA
National Advisory Committee, American Conference of Industrial
Hygienists, International Agency for Research on Cancer, Society of
Toxicology, and National Institutes of Health advisory committees.
    15. Raymond G. York, Ph.D., DABT, Fellow-ATS, RG York and
Associates, LLC.
    i. Expertise: Toxicology (developmental/reproductive and
neurotoxicology).
    ii. Education: University of Cincinnati, Ph.D. in Toxicology
(1982).
    iii. Professional Experience: Dr. York is a board-certified
Toxicologist and operates his own consulting company, RG York and
Associates, LCC. Dr. York received his Ph.D. in Toxicology at the
University of Cincinnati Medical Center in 1982 and completed a two-
year postdoctoral fellowship at the Children's Hospital Research
Foundation in Cincinnati in the area of developmental toxicology. He
has previously served as Senior Scientific Director at WIL Research
Laboratories (2008-2011), Associate Director of Research/Program
Manager at Charles River Laboratories (1995-2008), and Director of
Reproductive Toxicology and Neurotoxicology at International Research
and Development Corporation (now MPI Research) (1989-1995). Dr. York
was board-certified as a Diplomate of the American Board of Toxicology
in 1986 and served four years on its Board of Directors. His work focus
is in the field of toxicology, particularly reproductive and
developmental toxicology. Dr. York has served as a study director on
over 700 safety evaluation studies, published over 100 manuscripts,
review articles, book chapters and abstracts, and has been an invited
speaker at international conferences. He is currently on the EPA
Science Advisory Board for trimethylbenzene. Dr. York has also been a
member of the Society of Toxicology (SOT) since 1985 and the American
College of Toxicology since 1998. He is currently President of the
Reproductive and Developmental Toxicology Specialty Section of SOT. In
addition, Dr. York has been a member of the Teratology Society since
1984, and served as the President for both the Midwest Teratology
Association (1989) and the Middle Atlantic Reproduction and Teratology
Association (2004). He has served as a reviewer for Toxicology and
Applied Pharmacology and International Journal of Toxicology and as a
member of the Editorial Board of Fundamental and Applied Toxicology.

    Dated: April 22, 2014.
Nancy K. Stoner,
Acting Assistant Administer, Office of Water.
[FR Doc. 2014-09888 Filed 4-29-14; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 82, Number 126 (Monday, July 3, 2017)]
[Notices]
[Page 30851]
[FR Doc No: 2017-13963]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: RP17-838-000.
    Applicants: Kern River Gas Transmission Company.
    Description: Kern River Gas Transmission Company submits tariff
filing per 154.204: 2017 June Citadel Negotiated Rate to be effective
6/23/2017.
    Filed Date: 06/22/2017.
    Accession Number: 20170622-5158.
    Comment Date: 5:00 p.m. Eastern Time on Wednesday, July 5, 2017.

    Docket Numbers: RP17-839-000.
    Applicants: Kern River Gas Transmission Company.
    Description: Kern River Gas Transmission Company submits tariff
filing per 154.204: 2017 June Exelon Negotiated Rate to be effective 6/
24/2017.
    Filed Date: 06/23/2017.
    Accession Number: 20170623-5046.
    Comment Date: 5:00 p.m. Eastern Time on Wednesday, July 5, 2017.

    Docket Numbers: RP17-840-000.
    Applicants: Rockies Express Pipeline LLC.
    Description: Rockies Express Pipeline LLC submits tariff filing per
154.204: Neg Rate 2017-06-23 ConocoPhillips to be effective 6/24/2017.
    Filed Date: 06/23/2017.
    Accession Number: 20170623-5152.
    Comment Date: 5:00 p.m. Eastern Time on Wednesday, July 5, 2017.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and Sec.  385.214) on or
before 5:00 p.m. Eastern time on the specified comment date. Protests
may be considered, but intervention is necessary to become a party to
the proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: June 26, 2017.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2017-13963 Filed 6-30-17; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 94 (Thursday, May 15, 2014)]
[Notices]
[Pages 27937-27938]
[FR Doc No: 2014-11214]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Occupational Safety and Health Administration

Susan Harwood Training Grant Program, FY 2014

AGENCY: Occupational Safety and Health Administration (OSHA), Labor.

ACTION: Notice of availability of funds and solicitations for grant
applications (SGA) for Targeted Topic Training and Capacity Building
grants.

-----------------------------------------------------------------------

    Funding Opportunity No.: SHTG-FY-14-01 (Targeted Topic Training
grants).
    Funding Opportunity No.: SHTG-FY-14-02 (Capacity Building grants).
    Catalog of Federal Domestic Assistance No.: 17.502.
SUMMARY: This notice announces availability of approximately $3.5
million for Susan Harwood Training Program Targeted Topic Training
grants in two categories: Targeted Topic Training and Targeted Topic
Training and Educational Materials Development. This notice also
announces availability of approximately $3.5 million for Susan Harwood
Training Program Capacity Building grants in two categories: Capacity
Building Developmental and Capacity Building Pilot.

DATES:  Grant applications for Capacity Building grants must be
received electronically by the Grants.gov system no later than 11:59
p.m., ET, on Thursday, June 26, 2014. Grant applications for Targeted
Topic Training grants must be received electronically by the Grants.gov
system no later than 11:59 p.m., ET, on Monday, June 30, 2014.

ADDRESSES: The complete Susan Harwood Training Grant Program
solicitation for grant applications and all information needed to apply
for these funding opportunities are available at the Grants.gov Web
site, http://www.grants.gov.

FOR FURTHER INFORMATION CONTACT: Questions regarding the solicitations
for grant applications should be emailed to<EMAIL_ADDRESS>or
directed to Heather Wanderski, Program Analyst, or Jim Barnes,
Director, Office of Training Programs and Administration, at 847-759-
7700 (note this is not a toll-free number). Personnel will not be
available after 5:00 p.m., ET, on the application deadline, to answer
questions. To obtain further information on the Susan Harwood Training
Grant Program, visit the OSHA Web site at: http://www.osha.gov/dte/sharwood/index.html.
    Questions regarding Grants.gov should be emailed to
<EMAIL_ADDRESS>or directed to the Grants.gov Contact Center, at 1-
800-518-4726 (toll free number). The Contact Center is available 24
hours a day, 7 days a week. The Contact Center is closed on Federal
holidays.

Authority and Signature

    David Michaels, Ph.D., MPH, Assistant Secretary of Labor for
Occupational Safety and Health, directed the preparation of this
notice. The authority for this notice is Section 21 of the Occupational
Safety and Health Act of 1970, (29 U.S.C. 670), Public Law 111-117, and
Public Law 112-10, and Secretary of Labor's Order No. 1-2012 (77 FR
3912).

    Signed at Washington, DC, on May 12, 2014.
David Michaels,
Assistant Secretary of Labor for Occupational Safety and Health.
[FR Doc. 2014-11214 Filed 5-14-14; 8:45 am]
BILLING CODE 4510-26-P


[Federal Register Volume 85, Number 213 (Tuesday, November 3, 2020)]
[Notices]
[Pages 69634-69636]
[FR Doc No: 2020-24357]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2020-0311]

Notice of Availability of Record of Decision for the Final
Supplemental Environmental Impact Statement/Supplemental Overseas
Environmental Impact Statement for Mariana Islands Training and Testing

AGENCY: Coast Guard, DHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard is adopting portions of the Navy's Mariana
Islands Training and Testing (MITT) Final 2020 Supplemental
Environmental Impact Statement/Supplemental Overseas Environmental
Impact Statement (SEIS/SOEIS), dated June 2020. The Coast Guard is
doing this in its role as a cooperating agency to the lead agency,
which is the Department of the Navy. The Coast Guard is issuing a
Record of Decision to implement Alternative 2 to fully meet current and
future training requirements.

DATES: The Coast Guard's Record of Decision is dated October 9, 2020.

ADDRESSES: To view the full text of the ROD or the Final SEIS/SOEIS, go
to http://www.regulations.gov, insert MITT study area or USCG-2020-0311
in the ``Keyword'' box, and then click

``Search.'' Project documents, including the 2020 Final SEIS/SOEIS, are
also available on the ``2020 Mariana Islands Training and Testing Final
Supplemental EIS/OEIS'' web page at https://mitt-eis.com/. The 2015
Final EIS/OEIS can be accessed at https://mitt-eis.com/ as well at the
``2015 Mariana Islands Training and Testing EIS/OEIS Documents'' web
page.

FOR FURTHER INFORMATION CONTACT: For information about this Record of
Decision call or email Ms. Maile Norman, Office of Enforcement, U.S.
Coast Guard; telephone 1-808-535-3264, email<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

Abbreviations

CFR Code of Federal Regulations
FR Federal Register
MIRC Mariana Islands Range Complex
MITT Mariana Islands Training and Testing
ROD Record of Decision
SEIS Supplemental Environmental Impact Statement
SOEIS Supplemental Overseas Environmental Impact Statement
U.S.C. United States Code

Background and Legal Basis

    This Coast Guard Record of Decision (ROD) adopts portions of the
2020 Final Supplemental Environmental Impact Statement/Supplemental
Overseas Environmental Impact Statement (SEIS/SOEIS). This is necessary
because the Coast Guard plans to continue joint and independent
training and testing in the Mariana Islands Training and Testing (MITT)
study area with the Navy through at least December 31, 2027. The
purpose and need for the Coast Guard action is to allow Coast Guard
personnel to qualify and train, jointly with and independent of the
Navy, in the effective and safe operational use of Coast Guard vessels,
aircraft, and weapons under realistic conditions in the area where they
would operate and to ensure our Nation's maritime safety and security.
    The Coast Guard has broad, multifaceted authority for management of
activities over all waters subject to jurisdiction of the U.S. Coast
Guard's law enforcement and national defense mission authority, which
is based in 14 U.S.C. 102. This section requires the Coast Guard to:
    (1) Enforce federal law in waters of the U.S.;
    (2) Maintain maritime surveillance;
    (3) Enforce safety regulations; and
    (4) ``Maintain a state of readiness to function as a specialized
service in the Navy in time of war, including the fulfillment of
Maritime Defense Zone command responsibilities.''
    The Coast Guard conducts search and rescue missions under
authorities in 14 U.S.C. 102, 502, and 701. These missions are achieved
in part by conducting training and testing within the MITT study area
to develop, sharpen, and maintain tactics, coordination, and personnel
readiness.

Discussion

    The Navy solicited public comment on the Draft SEIS/SOEIS on
February 1, 2019 (84 FR 1119), and extended the public comment period
until April 17, 2019 (84 FR 12238). The Navy also scheduled and held
public meetings (84 FR 8515). The Navy announced its final SEIS/SOEIS
in the Federal Register on June 5, 2020.
    The MITT SEIS/SOEIS identified and examined the alternatives
available to achieve the purposes of the training and testing, and
assessed the potential environmental impact of each. Alternatives
considered but eliminated were continuing actions at levels identified
in the 2015 MITT Final EIS/OEIS and ROD, alternative training and
testing locations, reduced training and testing, alternatives including
geographic mitigation measures within the study area and simulated
training and testing only.
    Three alternatives were examined in detail in the SEIS/SOEIS.
    (1) No Action Alternative: Under the no action alternative, the
Navy, Air Force, and Coast Guard would not conduct the proposed
training and testing activities in the MITT study area. Other military
activities not associated with either Alternatives 1 or 2 would
continue to occur. For Farallon de Medinilla, the lease agreement
between the U.S. Government and the Commonwealth of the Northern
Mariana Islands would remain in place, and the island would continue to
be maintained as a Navy range, although strike warfare would no longer
continue on the island.
    (2) Alternative 1: Alternative 1 reflects a representative year of
training and testing to account for the typical fluctuation of training
cycles, testing programs, and deployment schedules that generally limit
the maximum level of training and testing from occurring for the
reasonably foreseeable future. Alternative 1 also reflects a level of
testing activities to be conducted into the reasonably foreseeable
future, with adjustments from the 2015 MITT Final EIS/OEIS that account
for changes in the types and tempo (increases or decreases) of testing
activities to meet current and future military readiness requirements.
    (3) Alternative 2 (Preferred Alternative): Alternative 2 includes
the same types of training activities as Alternative 1 but also
considers additional exercises and associated unit-level activities
should unanticipated emergent world events require increased readiness
levels. For example, Alternative 2 considers Joint Multi-Strike Group
Exercises (i.e., Valiant Shield) occurring annually as compared to
every other year under Alternative 1. Alternative 2 reflects the
maximum number of training activities that could occur within a given
year, and assumes that the maximum number of exercises would occur
annually. Alternative 2 entails a level of testing activities to be
conducted into the reasonably foreseeable future. Under Alternative 2,
types and tempos of testing activities would increase compared to
Alternative 1.
    Under Alternative 2, the Navy, Air Force, and Coast Guard will be
able to meet current and future Navy, Air Force, and Coast Guard
training and testing, including the use of aerial and vessel assets
conducting anchoring and gunnery training within the MITT study area.
These actions will allow joint and independent training and testing for
Navy, Air Force, and Coast Guard personnel to establish, maintain, and
advance readiness in meeting statutory mission requirements. For Coast
Guard, the MITT study area is composed of established sea-based (at-
sea) ranges along Guam and the Commonwealth of the Northern Mariana
Islands and operating areas and special use airspace in the regions of
the Mariana Islands that are part of the Mariana Islands Range Complex
(MIRC). The study area also includes a transit corridor that connects
the MIRC and the Hawaiian Islands Range Complex. For the Navy and Air
Force, the study area is the same as what is described for the Coast
Guard but also includes land-based training areas in Guam and the
Commonwealth of the Northern Mariana Islands.
    Alternative 2 was selected because it fulfills the purpose and need
of the proposed action and, in combination with avoidance and
mitigation measures, results in a minimum of environmental impacts.
    This notice is issued under authority of the National Environmental
Policy Act of 1969 (Section 102(2)(c)), as implemented by the Council
on Environmental Quality regulations (40 CFR 1500-1508), U.S. Coast
Guard Environmental Planning Policy (Coast Guard Commandant Instruction
5090.1), law enforcement and national defense mission authority at 14
U.S.C. 102, and search and rescue authority at 14 U.S.C. 102, 502, and
701.

    Dated: October 22, 2020.
Craig M. O'Brien,
Captain, 14th District, U.S. Coast Guard, Chief of Response.
[FR Doc. 2020-24357 Filed 11-2-20; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Rules and Regulations]
[Pages 55915-55916]
[FR Doc No: 2022-19764]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 100

[Docket No. USCG-2022-0653]

Special Local Regulation; Marine Events Within the Eleventh Coast
Guard District--San Diego Bayfair

AGENCY: Coast Guard, Department of Homeland Security (DHS).

ACTION: Notification of enforcement of regulation.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard will enforce the special local regulation on
the waters of Mission Bay, CA, during the San Diego Bayfair on
September 16, 2022, through September 18, 2022. This special local
regulation is necessary to provide for the safety of the participants,
crew, sponsor vessels of the event, and general users of the waterway.
During the enforcement period, persons and vessels are prohibited from
entering into, transiting through, or anchoring within this regulated
area unless authorized by the Captain of the Port, or his designated
representative.

DATES: The regulations in 33 CFR 100.1101 for the location listed in
Item 9 in table 1 to Sec.  100.1101 will be enforced from 6 a.m. until
6 p.m., each day from September 16, 2022, through September 18, 2022.

FOR FURTHER INFORMATION CONTACT: If you have questions about this
notification of enforcement, call or email Lieutenant Junior Grade
Shera Kim, Waterways Management, U.S. Coast Guard Sector San Diego, CA;
telephone<PHONE_NUMBER>, email [email protected].

SUPPLEMENTARY INFORMATION: The Coast Guard will enforce the special
local regulations in 33 CFR 100.1101 for the location identified in
Item 9 in table 1 to Sec.  100.1101, from 6 a.m. until 6 p.m., each day
from September 16, 2022 through September 18, 2022, for the San Diego
Bayfair in Mission Bay, CA. This action is being taken to provide for
the safety of life on the navigable waterways during the event. Our
regulation for recurring marine events in the San Diego Captain of the
Port Zone, Sec.  100.1101, Item No. 9 in table 1 to Sec.  100.1101
specifies the location of the regulated area for the San Diego Bayfair,
which encompasses portions of Mission Bay. Under the provisions of
Sec.  100.1101, persons and vessels are prohibited from entering into,
transiting through, or anchoring within this regulated area

unless authorized by the Captain of the Port, or his designated
representative. The Coast Guard may be assisted by other Federal,
State, or local law enforcement agencies in enforcing this regulation.
    In addition to this document in the Federal Register, the Coast
Guard will provide the maritime community with advance notification of
this enforcement period via the Local Notice to Mariners and marine
information broadcasts.

    Dated: September 7, 2022.
J.W. Spitler,
Captain, U.S. Coast Guard, Captain of the Port San Diego.
[FR Doc. 2022-19764 Filed 9-12-22; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register Volume 79, Number 40 (Friday, February 28, 2014)]
[Rules and Regulations]
[Pages 11320-11321]
[FR Doc No: 2014-04354]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 117

[Docket No. USCG-2014-0065]

Drawbridge Operation Regulation; Gulf Intracoastal Waterway,
Belle Chasse, LA

AGENCY: Coast Guard, DHS.

ACTION: Notice of deviation from drawbridge regulation.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard has issued a temporary deviation from the
operating schedule that governs the State Route 23 (SR 23) vertical
lift span bridge, also known as the Judge Perez Bridge, across the Gulf
Intracoastal Waterway (Algiers Alternate Route), mile 3.8, at Belle
Chasse, Plaquemines Parish, Louisiana. This deviation is necessary to
provide

for the safe movement of vehicular traffic during major plant
reconstruction on one side of the waterway and the resulting change in
work schedule and increase in workforce transiting the bridge. This
deviation allows the bridge to remain temporarily closed to navigation
for an additional one hour in the evening during weekdays for two
months.

DATES: This deviation is effective from 5:30 p.m. on Wednesday, March
5, 2014 through 6:30 p.m. on Wednesday, April 30, 2014.

ADDRESSES: The docket for this deviation, [USCG-2014-0065] is available
at http://www.regulations.gov. Type the docket number in the ``SEARCH''
box and click ``SEARCH.'' Click on Open Docket Folder on the line
associated with this deviation. You may also visit the Docket
Management Facility in Room W12-140 on the ground floor of the
Department of Transportation West Building, 1200 New Jersey Avenue SE.,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.

FOR FURTHER INFORMATION CONTACT: If you have questions on this
temporary deviation, call or email David Frank, Bridge Administration
Branch, Coast Guard; telephone<PHONE_NUMBER>, email
<EMAIL_ADDRESS>If you have questions on viewing the docket,
call Cheryl F. Collins, Program Manager, Docket Operations, telephone
202-366-9826.

SUPPLEMENTARY INFORMATION: A member of the Louisiana State Legislature
requested a temporary deviation from the operating schedule on the SR
23 vertical lift span bridge, also known as the Judge Perez Bridge,
across the Gulf Intracoastal Waterway (Algiers Alternate Route), mile
3.8, at Belle Chasse, Plaquemines Parish, Louisiana. The deviation
requested allows the bridge to remain closed to navigation for an
additional one hour in the evening, Monday through Friday, for two
months.
    The Louisiana Legislature makes this request to support and assist
in the safe movement of increased vehicular traffic across the bridge
during the evening hours, resulting from a change in the work schedule
and increased work force related to a major plant reconstruction at the
Conoco/Phillips Refinery in Alliance. This temporary deviation will
also help to minimize the effects of the additional traffic on local
residents.
    Presently, in accordance with 33 CFR 117.451(b), the draw shall
open on signal; except that, from 6 a.m. to 8:30 a.m. and from 3:30
p.m. to 5:30 p.m. Monday through Friday, except Federal holidays, the
draw need not open for the passage of vessels.
    This temporary deviation allows the vertical lift bridge to remain
closed to navigation for one additional hour in the afternoon to extend
the afternoon curfew hours from 3:30 p.m. to 6:30 p.m. Monday through
Friday from Wednesday, March 5, 2014 through Wednesday, April 30, 2014.
In case of an emergency, the bridge will be able to open for the
passage of vessels.
    The SR 23 vertical lift span drawbridge across the Gulf
Intracoastal Waterway (Algiers Alternate Route), mile 3.8, at Belle
Chasse, Louisiana has a vertical clearance of 40 feet above mean high
water in the closed-to-navigation position and 100 feet above mean high
water in the open-to-navigation position. Navigation on the waterway
consists primarily of tugs with tows, commercial fishing vessels, and
occasional recreational craft. Mariners may use the Gulf Intracoastal
Waterway (Harvey Canal) to avoid unnecessary delays. The Coast Guard
has coordinated this closure with the Gulf Intracoastal Canal
Association (GICA). The GICA representative indicated that the vessel
operators will be able to schedule transits through the bridge such
that operations will not significantly be hindered. Thus, it has been
determined that this closure will not have a significant effect on
these vessels.
    In accordance with 33 CFR 117.35, the draw bridge must return to
its regular operating schedule immediately at the end of the effective
period of this temporary deviation.
    This deviation from the operating regulations is authorized under
33 CFR 117.35.

    Dated: February 13, 2014.
David M. Frank,
Bridge Administrator.
[FR Doc. 2014-04354 Filed 2-27-14; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register Volume 86, Number 56 (Thursday, March 25, 2021)]
[Rules and Regulations]
[Pages 15791-15795]
[FR Doc No: 2021-06139]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2020-0700; Project Identifier AD-2020-00238-E;
Amendment 39-21461; AD 2021-05-18]
RIN 2120-AA64

Airworthiness Directives; International Aero Engines AG Turbofan
Engines

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The FAA is superseding Airworthiness Directive (AD) 2019-06-06
for all International Aero Engines AG (IAE) V2500-A1, V2522-A5, V2524-
A5, V2525-D5, V2527-A5, V2527E-A5, V2527M-A5, V2528-D5, V2530-A5, and
V2533-A5 model turbofan engines. AD 2019-06-06 required initial and
repetitive borescope inspections (BSIs) of the M-flange and, if it
fails the inspection, replacement of the diffuser case with a part
eligible for installation. This AD requires an initial BSI of the M-
flange and, if it fails the inspection, repetitive BSIs of the M-flange
until replacement of the diffuser case M-flange. The FAA is issuing
this AD to address the unsafe condition on these products.

DATES: This AD is effective April 29, 2021.
    The Director of the Federal Register approved the incorporation by
reference of a certain publication listed in this AD as of April 29,
2021.

ADDRESSES: For service information identified in this final rule,
contact International Aero Engines AG, 400 Main Street, East Hartford,
CT 06118; phone:<PHONE_NUMBER>; email<EMAIL_ADDRESS>website:
http://fleetcare.pw.utc.com. You may view this service information at
the FAA, Airworthiness Products Section, Operational Safety Branch,
1200 District Avenue, Burlington, MA 01803. For information on the
availability of this material at the FAA, call<PHONE_NUMBER>. It is
also available at https://www.regulations.gov by searching for and
locating Docket No. FAA-2020-0700.

Examining the AD Docket

    You may examine the AD docket at https://www.regulations.gov by
searching for and locating Docket No. FAA-2020-0700; or in person at
Docket Operations between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The AD docket contains this final rule, any
comments received, and other information. The address for Docket
Operations is U.S. Department of Transportation, Docket Operations, M-
30, West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue
SE, Washington, DC 20590.

FOR FURTHER INFORMATION CONTACT: Nicholas Paine, Aviation Safety
Engineer, ECO Branch, FAA, 1200 District Avenue, Burlington, MA 01803;
phone:<PHONE_NUMBER>; fax:<PHONE_NUMBER>; email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

Background

    The FAA issued a notice of proposed rulemaking (NPRM) to amend 14
CFR part 39 to supersede AD 2019-06-06, Amendment 39-19604 (84 FR
11642, March 28, 2019), (AD 2019-06-06). AD 2019-06-06 applied to all
IAE V2500-A1, V2522-A5, V2524-A5, V2525-D5, V2527-A5, V2527E-A5,
V2527M-A5, V2528-D5, V2530-A5, and V2533-A5 model turbofan engines. The
NPRM published in the Federal Register on September 9, 2020 (85 FR
55624). The NPRM was prompted by a crack found at the diffuser case M-
flange during overhaul inspection. Since the FAA issued AD 2019-06-06,
the manufacturer performed an updated safety risk analysis, which
resulted in reducing the M-flange inspection intervals and adding the
performance of a replacement of the diffuser case M-flange, which
terminates the need for repetitive BSIs of the M-flange. In the NPRM,
the FAA proposed to require an initial BSI of the M-flange and, if it
fails the inspection, repetitive BSIs of the M-flange until replacement
of the diffuser case M-flange.

Discussion of Final Airworthiness Directive

Comments

    The FAA received comments from six commenters. The commenters were
Air Line Pilots Association, International (ALPA); Cathay Dragon
Airways (Cathay); IAE; MTU Maintenance Hannover GmbH (MTU); Willis
Lease Finance Corporation (WLFC); and United Airlines (United). Five of
six commenters requested changes to this AD. One commenter requested an
update to Applicability. Two commenters requested clarification when
cycles are unknown or cannot be determined. Three commenters requested
that the FAA reference the latest service information. One commenter
requested an update to terminology. Three commenters requested credit
for replacement before the effective date of this AD. One commenter
requested clarification to ``engine shop visit.'' One commenter
requested an update to a Note in paragraph (g)(2) of this AD. One
commenter requested an update to include diffuser case assembly part
numbers (P/Ns) after modification. One commenter supported this AD as
written. The following presents the comments received on the NPRM and
the FAA's response to each comment.

Request To Update Applicability To Include IAE V2500-E5 Model Engines

    IAE requested that the FAA update paragraph (c), Applicability, of
this AD to include the IAE V2500-E5 model turbofan engine. IAE reasoned
that the V2500-E5 model turbofan engine shares diffuser case assembly,
P/N 2A2891-01, with IAE V2500-A1, -A5, and -D5 model turbofan engines.
    The FAA agrees that the IAE V2500-E5 model turbofan engine shares
an affected diffuser case assembly with other affected engines, and
therefore, is susceptible to the unsafe condition of this AD. The FAA
added the IAE V2531-E5 model turbofan engine to the Applicability of
this AD. The IAE V2531-E5 model turbofan engine is not currently
installed on any airplanes of U.S. registry. Therefore, this change to
applicability does not add any additional burden on U.S. operators or
increase the estimated cost of this AD.

Request To Clarify Compliance Time When Cycles Are Unknown or Cannot Be
Determined

    Cathay and WLFC requested clarification when to perform the actions
if the cycles since new (CSN) are unknown or cannot be determined.
Cathay suggested adding the following note to paragraphs (g)(1)(i),
(ii), and (iii) of this AD for the BSI of the M-flange to align this AD
with IAE Non-Modification Alert Service Bulletin (NMASB) V2500-ENG-72-
A0706, Revision 2, dated November 7, 2019 (the NMASB): ``If the cycles
on the diffuser case M-flange cannot be determined, you must use the
total cycles on the diffuser case. If the cycles on the diffuser case
cannot be determined, you must use the total engine cycles if it can be
documented that the diffuser case was always with the engine.'' WLFC
asked for clarification on the compliance time for the diffuser case M-
flange replacement.
    Although the FAA disagrees with adding the note suggested by
Cathay, the FAA agrees to clarify when to perform the actions if the
CSN are unknown or cannot be determined. The FAA updated paragraph
(g)(1)(iii) of this AD to clarify when to perform the initial

BSI of the M-flange and added paragraph (g)(2)(ii) of this AD to
clarify when to replace the diffuser case M-flange if the diffuser case
M-flange CSN are unknown or cannot be determined.

Request To Update Service Information

    IAE, MTU, and United requested that IAE Service Bulletin (SB)
V2500-ENG-72-0709, Revision 1, dated February 20, 2020 (the SB), be
referenced in this AD instead of the Original Issue, dated December 13,
2019. United also requested that ``IAE NMASB V2500-ENG-72-A0706,
Revision 2, dated November 7, 2019,'' be referenced.
    The FAA partially agrees. Revision 2 of the NMASB was already
referenced in the NPRM and, therefore, no change is needed to this AD.
The FAA agrees to reference Revision 1 to the SB, which was issued
after publication of the NPRM. The SB provides guidance on performing
the replacement of the diffuser case M-flange and is not required for
compliance with the AD. Therefore, revising this AD to reference
Revision 1 of the SB adds no additional burden on U.S. operators.

Request To Change ``Diffuser Case M-Flange'' References

    IAE requested that the FAA change ``diffuser case M-flange'' to
``M-flange'' when referencing inspections. IAE reasoned that inspection
zone 2 includes all three flanges of the M-flange: Diffuser case M-
flange, nozzle guide vane support, and the high-pressure turbine (HPT)
case forward flange, and all three flanges are required to be
inspected.
    The FAA agrees. The inspections are required on all surfaces of
inspection zones 1, 2, and 3 of the M-flange. The FAA changed
``diffuser case M-flange'' to ``M-flange'' when referencing inspections
throughout this AD. The FAA, however, did not change ``diffuser case M-
flange'' when referencing replacement. Replacement of the diffuser case
M-flange is the terminating action for the repetitive BSIs of the M-
flange required by this AD.

Request for Credit for Diffuser Case M-Flange Replacement

    Cathay, MTU, and WLFC requested credit for the replacement of the
diffuser case M-flange if it was replaced before the effective date of
this AD using TASK 72-42-11-300-028, Repair-028 (VRS3633), of the IAE
V2500 Engine Manual (VRS3633 Repair-028). Cathay and WLFC reasoned that
the replacement of the diffuser case M-flange resets the M-flange
cycles to zero. Cathay and MTU cited the note to VRS3633 Repair-028 in
the NMASB. Cathay also cited the note in the NMASB that fluorescent
penetrant inspection (FPI) of the diffuser case M-flange bolt holes
resets the cycles since the last FPI to zero.
    The FAA disagrees with revising the Credit for Previous Actions
section of this AD to give credit for replacement of the diffuser case
M-flange using VRS3633 Repair-028. The FAA determined that it is not
necessary to provide previous credit for replacement of the diffuser
case M-flange because this AD does not require use of specific service
information to perform this replacement. The FAA revised paragraph (i),
Credit for Previous Actions, of this AD by removing references to
providing credit for replacement of the diffuser case M-flange. If
operators replaced the diffuser case M-flange prior to the effective
date of this AD using any FAA-approved method, they meet the
requirements of this AD under paragraph (f) of this AD.

Request To Clarify ``Major Mating Engine Flanges''

    United requested that the FAA clarify the definition of ``engine
shop visit'' and ``major mating engine flange.'' United asked if
``major flange'' aligns with the NMASB, which in Figure 1 of the NMASB,
identifies the engine major flanges as H through P flanges. United also
asked if the ``separation of pairs of major mating engine flanges''
includes the separation of H and J flanges when replacing damaged
blades in HPC stages 3 through 6 during an HPC Surgical Strike Repair.
If an engine shop visit includes separating flanges when performing an
HPC Surgical Strike Repair, United requested that the FAA update
estimated costs of this AD to include costs associated with the
teardown of modules.
    The FAA agrees to clarify this definition of ``engine shop visit''
in this AD. The FAA has revised the definition of ``engine shop visit''
in this AD to refer to the induction of the engine into the shop for
maintenance involving the separation of pairs of major mating engine
flanges, K-N. Based on this definition, separating H and J flanges
during an HPC Surgical Strike Repair does not constitute an ``engine
shop visit.''
    The FAA disagrees with updating the estimated costs of this AD. The
cost analysis in AD rulemaking actions typically includes only the
costs associated with complying with the AD, and does not include
secondary costs. The FAA's cost estimate includes the work hours and
parts costs to inspect and replace the parts.

Request To Update Note to Paragraph (g)(2)

    MTU requested that the FAA update Note 1 to paragraph (g)(2)(i) of
this AD to ``Instructions on performing the replacement of the diffuser
case M-flange can be found in the Accomplishment Instructions,
paragraphs 1.A. and B., of IAE SB V2500-ENG-72-0709, Revision 1, dated
February 20, 2020.'' MTU reasoned that the current wording suggests
that there may be alternative instructions to replace the diffuser case
M-flange other than the SB. MTU suggested that there are no
alternatives to using IAE SB V2500-ENG-72-0709 to replace the diffuser
case M-flange. Therefore, MTU notes that the language in the NPRM may
generate ambiguity.
    The FAA disagrees. The SB is referenced in Note 2 to paragraph
(g)(2) of this AD as guidance for performing the replacement. The FAA
is not mandating the use of a specific method to replace the diffuser
case M-flange in this AD. The FAA did not change this AD based on this
comment, but redesignated ``Note 1 to paragraph (g)(2)(i)'' in the NPRM
to ``Note 2 to paragraph (g)(2)'' in this AD based on the addition of a
Note earlier in paragraph (g) of this AD.

Request To Include Diffuser Case Assembly P/Ns After Modification

    IAE requested that the FAA include the diffuser case assembly P/Ns,
modified by the SB that are re-identified with new P/Ns after
modification, and require replacement before the M-flange accumulates
20,000 CSN.
    The FAA disagrees with including the list of diffuser case assembly
P/Ns. The diffuser case M-flange, regardless of P/N, must be replaced
at the next engine shop visit after the effective date of this AD or
before the M-flange accumulates 20,000 CSN, whichever occurs later.
Thereafter, the diffuser case M-flange must be replaced before
accumulating 20,000 cycles since the previous replacement. Therefore,
listing diffuser case assembly P/Ns is unnecessary.

Clarification to BSI Requirement

    The FAA determined the need to clarify the instructions required by
paragraph (g)(1)(iv) of the NPRM. The NPRM referenced paragraphs 2.A.
through 2.G. of the NMASB to perform the BSI. However, paragraph 2.G.
of the NMASB provides instructions to perform a FPI of the M-flange to
confirm the indication as a crack. The FAA added a note to paragraph
(g)(1)(iv) of this AD to clarify that paragraph 2.G. of the NMASB
describes procedures for

performing a local FPI of the M-flange if you are unable to confirm if
an indication is a crack.

Support for the AD

    ALPA expressed support for the AD as written.

Conclusion

    The FAA reviewed the relevant data, considered any comments
received, and determined that air safety requires adopting the AD as
proposed. Accordingly, the FAA is issuing this AD to address the unsafe
condition on these products. Except for minor editorial changes, and
any other changes described previously, this AD is adopted as proposed
in the NPRM. None of the changes will increase the economic burden on
any operator.

Related Service Information Under 1 CFR Part 51

    The FAA reviewed International Aero Engines NMASB V2500-ENG-72-
A0706, Revision 2, dated November 7, 2019. The NMASB describes
procedures for inspecting the M-flange. This service information is
reasonably available because the interested parties have access to it
through their normal course of business or by the means identified in
ADDRESSES.

Other Related Service Information

    The FAA reviewed International Aero Engines SB V2500-ENG-72-0709,
Revision 1, dated February 20, 2020. The SB identifies the diffuser
case assembly P/Ns and describes procedures for replacing the diffuser
case M-flange.

Costs of Compliance

    The FAA estimates that this AD affects 1,654 engines installed on
airplanes of U.S. registry.
    The FAA estimates the following costs to comply with this AD:

                                                 Estimated Costs
----------------------------------------------------------------------------------------------------------------
                                                                                Cost per      Cost on U.S.
                Action                         Labor cost           Parts cost        product        operators
----------------------------------------------------------------------------------------------------------------
BSI of M-flange.......................  2 work-hours x $85 per                $0            $170        $281,180
                                         hour = $170.
Replace the diffuser case M-flange....  40 work-hours x $85 per           20,000          23,400      38,703,600
                                         hour = $3,400.
----------------------------------------------------------------------------------------------------------------

    The FAA has included all known costs in its cost estimate.
According to the manufacturer, however, some of the costs of this AD
may be covered under warranty, thereby reducing the cost impact on
affected operators.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, Section 106, describes the
authority of the FAA Administrator. Subtitle VII, Aviation Programs,
describes in more detail the scope of the Agency's authority.
    The FAA is issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701, General requirements
Under that section, Congress charges the FAA with promoting safe flight
of civil aircraft in air commerce by prescribing regulations for
practices, methods, and procedures the Administrator finds necessary
for safety in air commerce. This regulation is within the scope of that
authority because it addresses an unsafe condition that is likely to
exist or develop on products identified in this rulemaking action.

Regulatory Findings

    The FAA has determined that this AD will not have federalism
implications under Executive Order 13132. This AD will not have a
substantial direct effect on the States, on the relationship between
the national government and the States, or on the distribution of power
and responsibilities among the various levels of government.
    For the reasons discussed above, I certify that this AD:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Will not affect intrastate aviation in Alaska, and
    (3) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by:
0
a. Removing airworthiness directive 2019-06-06, Amendment 39-19604 (84
FR 11642, March 28, 2019); and
0
b. Adding the following new airworthiness directive:

2021-05-18 International Aero Engines AG: Amendment 39-21461; Docket
No. FAA-2020-0700; Project Identifier AD-2020-00238-E.

(a) Effective Date

    This airworthiness directive (AD) is effective April 29, 2021.

(b) Affected ADs

    This AD replaces AD 2019-06-06, Amendment 39-19604 (84 FR 11642,
March 28, 2019).

(c) Applicability

    This AD applies to all International Aero Engines AG (IAE)
V2500-A1, V2522-A5, V2524-A5, V2525-D5, V2527-A5, V2527E-A5, V2527M-
A5, V2528-D5, V2530-A5, V2531-E5, and V2533-A5 model turbofan
engines.

(d) Subject

    Joint Aircraft System Component (JASC) Code 7250, Turbine
Section.

(e) Unsafe Condition

    This AD was prompted by a crack found at the diffuser case M-
flange during overhaul inspection. The FAA is issuing this AD to
prevent failure of the diffuser case. The unsafe condition, if not
addressed, could result in uncontained diffuser case rupture, damage
to the engine, and damage to the airplane.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Required Actions

(1) Borescope Inspection of M-Flange

    For engines with a diffuser case assembly, part number 2A0051,
2A2081-01, 2A2581-01, 2A2883-01, 2A2885-01, 2A2889-01, 2A2891-01,
2A2896-01, 2A2897-01, or 2A3132 installed, perform an initial
borescope inspection (BSI) of zones 1, 2, and 3 of the M-flange as
follows:
    (i) For engines with a diffuser case M-flange that has 19,000 or
more cycles since

new (CSN) on the effective date of this AD, perform the initial BSI
of the M-flange before accumulating the ``Inspect within (Cycles)''
in Table 1 to paragraph (g)(1) of this AD. If the CSLFPI is unknown,
use the CSN of the diffuser case M-flange.
    (ii) For engines with a diffuser case M-flange that has fewer
than 19,000 CSN on the effective date of this AD, perform the
initial BSI of the M-flange before accumulating 20,300 CSN.
    (iii) For engines with a diffuser case M-flange or diffuser case
in which the CSN is unknown or cannot be determined, perform the
initial BSI of the M-flange before accumulating the ``Inspect within
(Cycles)'' in Table 1 to paragraph (g)(1) of this AD using one of
the following options:
    (A) If the cycles of the diffuser case M-flange are unknown or
cannot be determined, use the total cycles on the diffuser case.
    (B) If the cycles on the diffuser case are unknown or cannot be
determined and it can be documented that the diffuser case was
always installed on the engine, use total engine cycles.
    (C) If neither paragraph (g)(1)(iii)(A) or (B) applies, perform
the BSI of the M-flange within 250 cycles after the effective date
of this AD.
    (iv) Use the Accomplishment Instructions, paragraphs 2.A.
through 2.G. of IAE Non-Modification Alert Service Bulletin (NMASB)
V2500-ENG-72-A0706, Revision 2, dated November 7, 2019 (the NMASB),
to perform the initial BSI.

    Note 1 to paragraph (g)(1)(iv): Paragraph 2.G. of the NMASB
describes procedures for performing a local fluorescent penetrant
inspection of the M-flange if you are unable to confirm if an
indication is a crack.

    (v) If no crack is found as a result of the inspections required
by paragraphs (g)(1)(i) through (iv) of this AD, repeat the BSI of
zones 1, 2, and 3 of the M-flange at intervals not to exceed 2,100
cycles since the previous BSI.
    (vi) If a crack is found as a result of the inspections required
by paragraphs (g)(1)(i) through (iv) of this AD, replace the
diffuser case M-flange or repeat the BSI of zones 1, 2, and 3 of the
M-flange as specified by either ``Table 2: Fly on Limits'' or
``Table 4: Fly on Limits,'' in paragraph 2.H., Accomplishment
Instructions, of the NMASB as appropriate for the affected the
engine model.
[GRAPHIC] [TIFF OMITTED] TR25MR21.000

(2) Replacement of the Diffuser Case M-Flange

    (i) At the next engine shop visit after the effective date of
this AD or before the diffuser case M-flange accumulates 20,000 CSN,
whichever occurs later, replace the diffuser case M-flange.
    (ii) For engines with a diffuser case M-flange or diffuser case
in which the CSN is unknown or cannot be determined, perform one of
the following options:
    (A) If the cycles of the diffuser case M-flange are unknown or
cannot be determined, at the next engine shop visit after the
effective date of this AD or before the diffuser case accumulates
20,000 CSN, whichever occurs later, replace the diffuser case M-
flange.
    (B) If the cycles of the diffuser case are unknown or cannot be
determined, and if it can be documented that the diffuser case was
always installed on the engine, at the next engine shop visit after
the effective date of this AD or before the engine accumulates
20,000 CSN, whichever occurs later, replace the diffuser case M-
flange.
    (C) If the cycles on the diffuser case M-flange are unknown or
cannot be determined based on the criteria identified in paragraphs
(g)(2)(ii)(A) and (B), or it cannot be shown that the diffuser case
was always installed on the engine, at the next engine shop visit
after the effective date of this AD, replace the diffuser case M-
flange.

    Note 2 to paragraph (g)(2)(ii): Guidance on performing the
replacement of the diffuser case M-flange described in paragraphs
(g)(2)(i) and (ii) can be found in the Accomplishment Instructions,
paragraphs 1.A. and B., of IAE SB V2500-ENG-72-0709, Revision 1,
dated February 20, 2020.

    (iii) Thereafter, repeat the replacement of the diffuser case M-
flange before accumulating 20,000 cycles since the previous
replacement.
    (iv) Replacement of the diffuser case M-flange is the
terminating action for the repetitive BSIs required by paragraph
(g)(1) of this AD.

(h) Installation Prohibition

    After the effective date of this AD, do not install a diffuser
case onto any affected engine if the diffuser case M-flange has more
than 20,000 CSN.

(i) Credit for Previous Actions

    You may take credit for the initial BSIs that are required by
paragraphs (g)(1)(i) through (iii) of this AD, if you performed
those actions before the effective date of this AD using IAE NMASB
V2500-ENG-72-A0706, Revision 1, dated June 28, 2019, or Original
Issue, dated February 14, 2019; IAE V2500 Special Instruction (SI)
No. 341F-18, dated November 19, 2018; IAE V2500 SI No. 350F-18, Rev.
1, dated December 17, 2018; IAE V2500 SI No. 356F-18, Rev. 1, dated
January 9, 2019; IAE V2500 SI No. 372F-18, dated January 8, 2019; or
IAE V2500 Special SI No. 04F-19, dated January 14, 2019.

(j) Definition

    For the purpose of this AD, an ``engine shop visit'' is the
induction of the engine into the shop for maintenance involving the
separation of pairs of major mating engine flanges, K-N, except that
the separation of engine flanges solely for the purposes of
transportation without subsequent engine maintenance does not
constitute an engine shop visit.

(k) Alternative Methods of Compliance (AMOCs)

    (1) The Manager, ECO Branch, FAA, has the authority to approve
AMOCs for this AD, if requested using the procedures found in 14 CFR
39.19. In accordance with 14 CFR 39.19, send your request to your
principal inspector or local Flight Standards District Office, as
appropriate. If sending information directly to the manager of the
certification office, send it to the attention of the person
identified in Related Information. You may email your request to:
<EMAIL_ADDRESS>    (2) Before using any approved AMOC, notify your appropriate
principal inspector, or lacking a principal inspector, the manager
of the local flight standards district office/certificate holding
district office.

(l) Related Information

    For more information about this AD, contact Nicholas Paine,
Aviation Safety Engineer, ECO Branch, FAA, 1200 District Avenue,
Burlington, MA 01803; phone:<PHONE_NUMBER>; fax:<PHONE_NUMBER>;
email<EMAIL_ADDRESS>
(m) Material Incorporated by Reference

    (1) The Director of the Federal Register approved the
incorporation by reference (IBR) of the service information listed
in this paragraph under 5 U.S.C. 552(a) and 1 CFR part 51.
    (2) You must use this service information as applicable to do
the actions required by this AD, unless the AD specifies otherwise.
    (i) International Aero Engines (IAE) Non-Modification Alert
Service Bulletin V2500-ENG-72-A0706, Revision 2, dated November 7,
2019.
    (ii) [Reserved]
    (3) For IAE service information identified in this AD, contact
International Aero Engines AG, 400 Main Street, East Hartford, CT
06118; phone:<PHONE_NUMBER>; email<EMAIL_ADDRESS>website:
http://fleetcare.pw.utc.com.
    (4) You may view this service information at FAA, Airworthiness
Products Section, Operational Safety Branch, 1200 District Avenue,
Burlington, MA 01803. For information on the availability of this
material at the FAA, call<PHONE_NUMBER>.
    (5) You may view this service information that is incorporated
by reference at the National Archives and Records Administration
(NARA). For information on the availability of this material at
NARA, email<EMAIL_ADDRESS>or go to: https://www.archives.gov/federal-register/cfr/ibr-locations.html.

    Issued on February 25, 2021.
Gaetano A. Sciortino,
Deputy Director for Strategic Initiatives, Compliance & Airworthiness
Division, Aircraft Certification Service.
[FR Doc. 2021-06139 Filed 3-24-21; 8:45 am]
BILLING CODE 4910-13-P